reference/22190687

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22190687

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	477
issn	1524-4741 1075-122X
issueIdentifier	5
pageRange	470-477
publicationName	The Breast Journal
startingPage	470
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_95d40357f1e57287004d8282328df95b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_af14823559724257c393aaf01ee2df88 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_04fc58a168780b9d489b25b727b9e2fa http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bcf177961e430f607222697ff32343fa
bibliographicCitation	Arowolo OA, Njiaju UO, Ogundiran TO, Abidoye O, Lawal OO, Obajimi M, Adetiloye AV, Im HK, Akinkuolie AA, Oluwasola A, Adelusola K, Kayode AA, Agbakwuru AE, Oduntan H, Babalola CP, Fleming G, Olopade OC, Falusi AG, Durosinmi MA, Olopade OI. Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study. Breast J. 2013 Sep;19(5):470–7. PMID: 23865786; PMCID: PMC4282544.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93135f946821f4c7c3809d8b102f5f6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c4b34335b7d41e339ba1ea50f8edc82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd270ceb459dc104880ad80e09f2cde3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14659264d9f689348c980ff2399e79e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f01ea505acad6f84d667803d5f1955b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1a6d75d8d9a54d1deb1d19448b5fbd8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8353d643cb4e7dd151222b5b2a44976 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef5a959468927ed101cec2ae5f6b6d5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca1cdcc0fe3066960ef08803b87e3268 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e8878548f774f435b92a35978feb5ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40bf8d2cda53a53a8f8486fbfac9f6a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c36fe2e06d22a549205686ff49cf07bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9cda2a99de031ff715b429b68c0aa23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4081b995fb7714cdf411822b0dcfb14e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12d72347f2658422fa79313ad26bdc7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58107e83cd85e07baca312a4211531b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70b0bee6536d4c0913fb7b27b34d7435 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d273352a45504c43aa339e6f36c7f18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f96780ff1373ffcbb91beace1b7a4c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d03381ec47adbc445ce10f0625590ec7
date	2013-07-19^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/tbj.12149 https://pubmed.ncbi.nlm.nih.gov/PMC4282544 https://pubmed.ncbi.nlm.nih.gov/23865786
isPartOf	https://portal.issn.org/resource/ISSN/1075-122X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22310 https://portal.issn.org/resource/ISSN/1524-4741
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neo‐adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource‐poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study
discusses	http://id.nlm.nih.gov/mesh/M0287377 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0008631 http://id.nlm.nih.gov/mesh/M0001471
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D000964Q000627 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D005472Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005472Q000627 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003841Q000627 http://id.nlm.nih.gov/mesh/D003841Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000069287 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005472Q000009 http://id.nlm.nih.gov/mesh/D009549 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005240
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11386 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Showing number of triples: 1 to 70 of 70.